approved EB-2 (NIW)

Associate Scientist

Virology · Taiwan · 2023-06-01

Processing Time
8 days
Decision Date
2023-06-01
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop a high-throughput screening platform to study factors involved in viral replication. This work aims to create better diagnostic and treatment strategies for emerging infectious diseases, specifically targeting SARS-CoV-2 and enterovirus to reduce their health and economic impacts.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses emerging infectious diseases which have a major impact on the U.S. healthcare system and economy.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a Ph.D. and a record of 14 publications and 785 citations, showing a history of productivity and expertise.

3 Waiver Benefit Met

On balance, the urgency of virology research to prevent public health crises justifies waiving the job offer requirement.

Why This Petition Was Approved

The case was approved based on the petitioner's Ph.D. in biomedical sciences and a strong record of 14 peer-reviewed journal articles with 785 citations. Additional evidence included 1 published U.S. patent and 4 expert recommendation letters confirming the urgency of his research for the U.S. healthcare system.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Dependent
Original Contributions

Similar Cases

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Florida 5 days 2024-07-30
The petitioner proposes to continue researching viral pathogenesis and host-virus interactions to unravel the mechanisms of viral replication, transmission, and pathogenesis. This work aims to design vaccines, antiviral drugs, and diagnostic tools to combat viral threats and mitigate pandemics.

Research Scientist

Research and Development · India

WeGreened EB-2 (NIW) approved
Georgia 68 days 2025-02-27
The petitioner proposes to develop diagnostic assays and platforms to study infectious viruses to enable rapid containment of emerging diseases. This work focuses on advancing tools for the detection of viral pathogens and supporting antiviral and vaccine efficacy testing.

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Massachusetts 30 days 2025-06-07
The petitioner proposes to develop and apply advanced immunological and virological methodologies to investigate viral persistence and immune response mechanisms. The work specifically focuses on chronic diseases such as HIV and Epstein-Barr Virus (EBV) to advance therapeutic strategies and vaccine development. This research aims to lower disease burdens and improve public health outcomes by addressing infectious disease control.

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Kansas 6 days 2024-01-31
The petitioner proposes to advance research on utilizing next-generation sequencing methods for virus characterization and investigating the molecular mechanisms of virus-cell interactions. This work aims to develop robust and accurate diagnostic assays and vaccines for emerging animal viral pathogens and human oncogenic viruses.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-06-01.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 8 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist